Adiponectin expression is decreased in metabolic disorders, such as obesity and related diseases [17]; in contrast, in autoimmune diseases, such as MS and rheumatoid arthritis, its expression is increased and correlated with a more severe prognosis [18, 19]. This evidence concerns the gene ADIPOQ and myeloid sarcoma.